Actively Recruiting

Age: 0 - 29Days
All Genders
Healthy Volunteers
NCT07249996

Respiratory Infections in Young Children

Led by Eduardo Lopez -Medina · Updated on 2025-11-25

1088

Participants Needed

2

Research Sites

399 weeks

Total Duration

On this page

Sponsors

E

Eduardo Lopez -Medina

Lead Sponsor

M

Merck Sharp & Dohme LLC

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to learn about the causes, severity, and long-term effects of respiratory tract infections (RTIs) in young children from birth to five years of age in Colombia and Panamá. The main questions it aims to answer are: How often do respiratory infections occur in children under two years old, and which viruses or bacteria cause them? Why do some children develop more severe infections than others? Do early infections or vaccinations change how the immune system responds to future illnesses? How do viruses and bacteria interact in the respiratory tract to influence disease severity and long-term respiratory health? Researchers will follow newborns from birth until age five to understand how respiratory infections develop and affect children's health over time. Participants will not receive any experimental treatment. Families who join the study will: Be contacted twice a week through a phone app or phone calls to check for symptoms of respiratory infection. Attend in-person visits if their child becomes ill and every six months for routine follow-up. Provide nasal and blood samples during illness episodes so researchers can identify the viruses or bacteria causing infection and study how the immune system responds. This study began in May 2024 and is being conducted in Cali, Colombia, and Panamá City, Panamá. The research team plans to continue to include participants and continue active follow-up until the children reach five years of age. The information collected will help scientists and health professionals understand how different pathogens cause respiratory infections, what factors increase the risk of severe illness, and how early infections may influence long-term lung health. The study's findings will support future efforts to prevent and treat respiratory diseases in young children.

CONDITIONS

Official Title

Respiratory Infections in Young Children

Who Can Participate

Age: 0 - 29Days
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Newborns younger than 29 days of life, with or without pre-existing conditions
  • Parent(s) or guardian(s) must be available for telephone contact throughout the study and not planning to move outside the study area
  • Parent(s) or guardian(s) must provide informed consent to participate
  • Parent(s) or guardian(s) must agree to data and specimen collection, storage, and analysis
Not Eligible

You will not qualify if you...

  • Infants born to mothers younger than 14 years of age at pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Centro de Estudios en Infectologia Pediatrica, CEIP

Cali, Valle del Cauca Department, Colombia

Actively Recruiting

2

Cevaxin

Panama City, Panama

Actively Recruiting

Loading map...

Research Team

E

Eduardo Lopez-Medina, MD, MSc

CONTACT

R

Rodrigo DeAntonio, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here